Prognostic microRNAs in patients operated for pancreatic cancer. This is an ASCO Meeting Abstract from the 2011 ASCO Annual Meeting I. This abstract does not include a full text component.

Show More From the Departments of Molecular Virology, Immunology and Medical Genetics and Comprehensive Cancer Center, Ohio State University, Columbus, OH; Departments of Pathology and Surgical and ...

The Geniom® RT Analyzer, a new benchtop microarray processing instrument, was presented by febit at Select Bioscience’s “Advances in Microarray Technology”. The platform complements Geniom® One, the ...

VEDBAEK, Denmark, Jan. 24, 2011 (GLOBE NEWSWIRE) -- Exiqon A/S (Copenhagen:EXQ), a leading supplier of high-value gene expression analysis products, today announced the launch of the 3rd generation of ...

Many key biological processes are impacted by miRNAs, including cell growth and proliferation, tissue differentiation, embryonic development, and apoptosis. Mutation, dysfunction, and/or dysregulation ...

Feb. 1, 2011, 8:45 AM UTC / Source: GlobeNewswire COPENHAGEN, Denmark, Feb. 1, 2011 (GLOBE NEWSWIRE) -- Exiqon A/S (Copenhagen:EXQ) today announced the launch of its 2011 global research grant program ...